Food and Drug Administration (FDA) officially approved the GLP-1 medication Ozempic to help reduce the risk of worsening kidney disease in adults with type 2 diabetes and chronic kidney disease
Most health insurance plans sort medications into three to five tiers, with higher tiers carrying higher out-of-pocket costs to the patient
Meurot C, Jacques C, Martin C, Sudre L, Breton J, Rattenbach R, Bismuth K, Berenbaum F
Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss
A NewYork-Presbyterian study confirmed that women in menopause benefit from GLP-1 weight loss medications as much as younger women, dispelling the common concern that these medications might be less effective after menopause